Response Biomedical expands distribution of cardiovascular products in the U.S.

Vancouver's Response Biomedical Corp. (TSC: RBM) (OTCBB: RPBIF) has entered into a distribution agreement with Laboratory Supply Company, Inc. (LABSCO) in Louisville, Kentucky, to distribute ...

Vancouver's Response Biomedical Corp. (TSC: RBM) (OTCBB: RPBIF) has entered into a distribution agreement with Laboratory Supply Company, Inc. (LABSCO) in Louisville, Kentucky, to distribute cardiovascular products in the U.S. to hospitals with fewer than 150 beds.

LABSCO is the largest privately held distributor of clinical lab products in the U.S.

"This is a very important agreement for Response as it marks a significant step into the U.S. market for POCT [point-of-care testing] in the cardiovascular areana, which is one of the largest markets in the world," said Tim Shannon, Response Biomedical Corp.'s senior vice-president of worldwide sales and marketing.

"LABSCO has the experience and reputation to maximize our efforts to gain traction and to help us penetrate a market that we believe will greatly enhance our growth in the near term and beyond."

The POCT market in the U.S. is worth an estimated $3.1 billion.

ecrawford@biv.com

@EmmaCrawfordBIV

comments powered by Disqus

Also Read

More From Technology

Porter Airlines has agreed to pay a $150,000 over allegations it...

Read Article

Ballard (TSX: BLD) is adding 85 more patents to its portfolio as part of a $30-million deal to acquire a U.S. company specializing in fuel ...

Read Article

Tyler Orton discusses the second day of trading for B.C. company Mogo

Read Article

Vancouver’s QuickMobile has expanded its team to Asia for the first time, opening a satellite office in Singapore. 

Read Article

Tyler Orton on a new ranking of wireless companies in B.C.

Read Article

Subscribe to our mailing lists

* indicates required

Newsletters

* You can modify your newsletter subscriptions at the bottom of any newsletter you receive.
×